Image
|
Figure Caption
FIGURE 1
Summary of patient treatment. Before the development of malignant ascites, the patient received three lines of anti‐HER2 treatment for metastatic disease and following disease progression. FEC, fluorouracil, epirubicin, and cyclophosphamide; TH, docetaxel and trastuzumab; PD, progressive disease
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Cancer Med